使用分子动力学模拟研究拉索福西芬对Y537S+F404V双突变雌激素受体α的疗效
El Mehdi Bouricha1,2, Mohammed Hakmi1,2
1Mohammed VI University of Sciences and Health, Morocco.
Bioinformatics and biology insights
|October 10, 2024
概括
雌激素受体α (ERα) 的双重Y537S和F404V突变可能会降低lasofoxifene在乳腺癌 (BC) 治疗中的疗效. 这会影响转移性BC患者的药物结合和有效性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 雌激素受体α (ERα) 对于ERα阳性乳腺癌 (BC) 的进展至关重要.
- 内分泌疗法耐药性可以由于ERα带结合域 (LBD) 突变而发展.
- 拉索福西芬对常见的ERα LBD突变,如Y537S和D538G,显示出有效性.
研究的目的:
- 调查新型双Y537S和F404V突变对拉索福西芬疗效的影响.
- 了解潜在的对拉索福西芬耐药性的分子机制.
主要方法:
- 分子动力学 (MD) 模拟.分子动力学 (MD) 模拟.
- 分子力学/Poisson-Boltzmann表面积 (MM-PBSA) 的自由能量计算.
- 分析蛋白质 - 连接体相互作用和构造变化.
主要成果:
- 双重Y537S和F404V突变显著降低了lazofoxifene的结合亲和力和自由能量.
- 关键的蛋白质-连接体相互作用被双重突变破坏.
- 在ERα LBD中发生了显著的形状变化,可能是由于F404V的pi-pi堆叠损失.
结论:
- 双重Y537S和F404V突变可能会降低ERα阳性转移性乳腺癌中lasofoxifene的疗效.
- 需要进一步的实验研究来验证这些计算发现.
- 了解双重突变效应对于优化BC的内分泌治疗至关重要.
更多相关视频
15:05Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
8.5K
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
440
相关概念视频
02:18The Equilibrium Binding Constant and Binding Strength
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
00:49Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...